Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03595280 · ClinicalTrials.gov registry record · NA
Optimizing Risk Messages for Waterpipe Tobacco Cessation in Young Adults
A NA study of Hookah Smoking, sponsored by Georgetown University.
- Completed
- Registry status
- NA
- Development phase
- 349
- Enrollment target
- 2
- Study locations
NCT03595280: Completed NA study of Hookah Smoking, sponsored by Georgetown University.
NCT03595280 is a NA study of Hookah Smoking that has completed, run by Georgetown University. The registered enrollment target is 349 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03595280, a NA study of Hookah Smoking, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 349 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objective of this study is to examine whether messages conveying the harms and addictiveness of waterpipe (i.e., hookah) tobacco delivered by mobile phone multimedia messaging (MMS) are effective for promoting hookah tobacco cessation among young adults ages 18 to 30 years.
Primary Outcome
Perceived harm of hookah tobacco is measured using valid self-report item assessing perceptions of how likely harms are to occur from hookah tobacco use (response range 1 no chance to 7 certain to happen). Greater perceived likelihood of harm is considered a better outcome. The assessment is administered immediately post intervention, 3-month follow-up, and 6-month follow-up, 6 month follow-up data reported.
Conditions Studied
Interventions
- BEHAVIORAL Hookah tobacco risk messages
Study Locations (2)
District of Columbia
- Georgetown University - Washington D.C.
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 349 participants |
| Start Date | 2018-08-28 |
| Est. Completion | 2021-07-01 |
| Phase | NA |
What the finished NCT03595280 record still lists
NCT03595280 is an interventional study that assigns participants to a tested intervention. The registered 349 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Hookah Smoking appearing as the primary indexed condition, and to 1 intervention - of which Hookah tobacco risk messages is the first listed.
NCT03595280 reports a single indexed study location in District of Columbia, North Carolina.
Frequently Asked Questions
What is clinical trial NCT03595280 about?
NCT03595280 is a clinical study titled "Optimizing Risk Messages for Waterpipe Tobacco Cessation in Young Adults". The objective of this study is to examine whether messages conveying the harms and addictiveness of waterpipe (i.e., hookah) tobacco delivered by mobile phone multimedia messaging (MMS) are effective for promoting hookah tobacco cessation among young adults ages 18 to 30 years.
What is the current status of trial NCT03595280?
This trial is currently completed. It is a NA study. The enrollment target is 349 participants. The study started on 2018-08-28. Estimated completion is 2021-07-01.
What conditions does trial NCT03595280 study?
This clinical trial studies the following conditions: Hookah Smoking.
What interventions are being tested in trial NCT03595280?
The interventions under investigation include: Hookah tobacco risk messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT03595280?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03595280 being conducted?
This trial has 2 study locations across District of Columbia, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hookah Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03595280's enrollment target sits among peer trials
349 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI